Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Current Assets: 2013-2025

Historic Current Assets for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $118.5 million.

  • Fortress Biotech's Current Assets rose 37.35% to $118.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.5 million, marking a year-over-year increase of 37.35%. This contributed to the annual value of $90.4 million for FY2024, which is 22.77% down from last year.
  • As of Q3 2025, Fortress Biotech's Current Assets stood at $118.5 million, which was up 7.34% from $110.4 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Current Assets peaked at $346.5 million during Q4 2021, and registered a low of $86.3 million during Q3 2024.
  • For the 3-year period, Fortress Biotech's Current Assets averaged around $117.9 million, with its median value being $116.5 million (2024).
  • Its Current Assets has fluctuated over the past 5 years, first surged by 100.25% in 2021, then slumped by 62.08% in 2023.
  • Quarterly analysis of 5 years shows Fortress Biotech's Current Assets stood at $346.5 million in 2021, then tumbled by 33.49% to $230.4 million in 2022, then tumbled by 49.22% to $117.0 million in 2023, then fell by 22.77% to $90.4 million in 2024, then surged by 37.35% to $118.5 million in 2025.
  • Its Current Assets was $118.5 million in Q3 2025, compared to $110.4 million in Q2 2025 and $126.9 million in Q1 2025.